SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-072188
Filing Date
2022-06-17
Accepted
2022-06-17 08:28:16
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218714-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2218714-6_4seq1.xml 4 3960
  Complete submission text file 0001104659-22-072188.txt   5678
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451
Business Address
Seehra Jasbir (Reporting) CIK: 0001732369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 221022464